These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 38453634)
1. Defense and anti-defense mechanisms of bacteria and bacteriophages. Wang X; Leptihn S J Zhejiang Univ Sci B; 2024 Feb; 25(3):181-196. PubMed ID: 38453634 [TBL] [Abstract][Full Text] [Related]
2. Evolutionary Dynamics between Phages and Bacteria as a Possible Approach for Designing Effective Phage Therapies against Antibiotic-Resistant Bacteria. Hasan M; Ahn J Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884169 [TBL] [Abstract][Full Text] [Related]
3. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems. Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767 [TBL] [Abstract][Full Text] [Related]
4. Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair. Wu X; Zhu J; Tao P; Rao VB mBio; 2021 Jun; 12(3):e0136121. PubMed ID: 34154416 [TBL] [Abstract][Full Text] [Related]
5. The interaction of phages and bacteria: the co-evolutionary arms race. Safari F; Sharifi M; Farajnia S; Akbari B; Karimi Baba Ahmadi M; Negahdaripour M; Ghasemi Y Crit Rev Biotechnol; 2020 Mar; 40(2):119-137. PubMed ID: 31793351 [TBL] [Abstract][Full Text] [Related]
6. The never-ending battle between lactic acid bacteria and their phages. Philippe C; Cornuault JK; de Melo AG; Morin-Pelchat R; Jolicoeur AP; Moineau S FEMS Microbiol Rev; 2023 Jul; 47(4):. PubMed ID: 37353926 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the CRISPR-Cas system in bacteriophages active on epidemic strains of Vibrio cholerae in Bangladesh. Naser IB; Hoque MM; Nahid MA; Tareq TM; Rocky MK; Faruque SM Sci Rep; 2017 Nov; 7(1):14880. PubMed ID: 29093571 [TBL] [Abstract][Full Text] [Related]
8. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses. Pons BJ; Dimitriu T; Westra ER; van Houte S Proc Natl Acad Sci U S A; 2023 Jan; 120(4):e2216084120. PubMed ID: 36669116 [TBL] [Abstract][Full Text] [Related]
9. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens. Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428 [TBL] [Abstract][Full Text] [Related]